Denmark· DK-28105911017
Segluromet
A metformin and ertugliflozin product containing ertugliflozinpidolat, metforminhydrochlorid, registered in Denmark by Merck Sharp & Dohme B.V.. The same ATC class is registered in 8 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Metformin and ertugliflozin is registered in 8 of 19 countries.
Countries holding a registration under ATC A10BD23 (metformin and ertugliflozin), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 5 of them publish a price we can compare per daily dose
Metformin and ertugliflozin · ATC A10BD23
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Ertugliflozinpidolat, METFORMINHYDROCHLORID
- Manufacturer
- Merck Sharp & Dohme B.V.
- Country
- Denmark (DK)
- ATC code
- A10BD23
- ATC class
- Metformin and ertugliflozin
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28105911017
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A10BD23
Metformin and ertugliflozin, as other registers publish it.
- PolandSeglurometMerck Sharp & Dohme B.V.
- PolandSeglurometMerck Sharp & Dohme B.V.
- PolandSeglurometMerck Sharp & Dohme B.V.
- FinlandSeglurometMerck Sharp & Dohme B.V.
- FinlandSeglurometMerck Sharp & Dohme B.V.
- FinlandSeglurometMerck Sharp & Dohme B.V.
- DenmarkSeglurometMerck Sharp & Dohme B.V.
- IcelandSeglurometMerck Sharp & Dohme B.V.*
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/01301414-a921-403c-b218-92045a161a4f GET /v1/drugs/01301414-a921-403c-b218-92045a161a4f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "filmovertrukne tabletter",
"source": "dkma",
"strength": "2,5+850 mg",
"auth_role": "MOD",
"dk_drugid": "28105911017",
"substance": "Ertugliflozinpidolat, METFORMINHYDROCHLORID",
"auth_procedure": "Central",
"in_medicinpriser": false,
"registration_date_serial": "43182"
}See everything about metformin and ertugliflozin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.